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AbstrACt:  background: cerebral palsy (cP) is the most common cause 
of physical disability affecting gross motor function (gmf) in early childhood. 
hippotherapy is a treatment approach aimed at improving gmf in children with 
cP. Several systematic reviews have been published showing an improvement in 
Dimension e of the gross motor function measure (gmfm) after hippotherapy. 
however, these reviews failed to evaluate the clinical effect of hippotherapy in 
improving gmf in children with cP. 
Objective: To critically appraise the evidence of hippotherapy to ascertain 
whether it is a clinically meaningful approach for children with cP. 
methodology: five computerised bibliographic databases were searched. Pre-
determined inclusion and exclusion criteria were set. The PeDro scale was used 
to assess the quality of the studies. A revised JBI Data extraction tool was used 
to extract data from the selected articles. Revman© Review manager Software was 
used to create forest plots for comparisons of results. 
Results: All studies used the gmfm as an outcome measure for gross motor 
function.  The added benefit of hippotherapy is a minimum 1% and a maximum 7% increase on the gmfm scores. however, all 
95% confidence intervals (ci) around all the mean differences were insignificant. 
conclusion: The clinical effect of hippotherapy on the gmf of children with cP is small. larger studies are required to provide 
evidence of the effect of hippotherapy within this population.  
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reflexes, tremors, muscular hyperto nicity 
and weakness (Krigger 2006). The topo­
graphic distributions are mono plegia, 
hemiplegia, diplegia and quadriplegia 
(O’Shea 2008).  The classification of 
movement disorders assists in selecting 
the most appropriate management stra­
tegies for motor disturbances of children 
with CP.
Hippotherapy, also known as equine­ 
assisted therapy, dates back to ancient 
Greece, but it has only gained popu larity 
as a treatment technique in the 1960’s 
when it was prescribed for mental, phy­
sical and emotional issues (Meregillano 
2004). It is a form of horseback riding 
that makes use of the smooth, rhythmical 
and reciprocal movement of the horse 
to address the physical limitations, func­
tional impairments and disabilities of 
the rider (McGee and Reese 2009). Hip­
potherapy has been shown to improve 
iNtRODUctiON
Cerebral palsy (CP) is the most com­
mon cause of physical disability in early 
childhood (Krägeloh­Mann and Cans 
2009). CP is a permanent developmen­
tal disorder, which is attributed to non­
progressive lesions that occur in the 
developing brain before or after birth 
(Rosenbaum et al 2007). The consequent 
impairment manifestations include 
scissoring gait, increased deep tendon 
flexibility, posture, balance and mobi­
lity of the rider (Snider et al 2007). It is 
proposed that when the horse moves, its 
centre of gravity changes three­dimen­
sionally and its movement simulates 
the movement of a person’s pelvis dur­
ing ambulation (Drnach et al 2010). It 
promotes righting and balance reactions 
when the rider attempts to maintain the 
trunk and head upright during movement 
(Snider et al 2007). The reported bene­
fits of hippotherapy include improved 
gait kinematics (Kulkarni­Lambore et al 
2001) and energy expenditure (McGib­
bon et al 1998). Improvement in tone 
assists with function in sitting, standing 
and walking.  Children that were exposed 
to hippotherapy showed improved self­
confidence with less fear of movement 
and position change. 
To date four reviews related to 
the effect of hippotherapy have been 
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pu blished. Two of these reviews are 
out dated and were published in 2007 
(Snider 2007, Sterba 2007). The review 
by Whalen and Case­Smith (2011) indi­
cated that hippotherapy is beneficial, but 
failed to provide the critical appraisal 
of the eligible trials. A recent review 
by Tseng et al (2012) presented a meta­
analysis, which is not appropriate due 
to variations in the type and duration of 
the interventions and study participants. 
This review also failed to comment on 
the size of the expected clinical effect 
on GMF which can assist clinicians in 
making appropriate clinical decisions.
The aim of this systematic review 
is therefore to critically appraise the 
evidence of hippotherapy or therapeutic 
horse riding (THR) to ascertain whether 
it has a clinically meaningful effect on 
GMF in children with CP. Therapeutic 
horseback riding (THR) is defined as 
using horseback riding treatment to 
improve posture, balance, and mobility 
while developing a therapeutic bond 
between the patient and horse”
ObJectives:
The specific objectives of the review 
were to:
• Compare whether hippotherapy or 
THR, is more clinically meaning­
ful in the short as well as long term 
(longer than 12 months), in improv­
ing gross motor function compared to 
usual therapies,
• Describe the type and dosage of usual 
therapies employed in eligible stu­
dies, 
• Describe the type and dosage of 
hippotherapy employed in eligible 
studies,
• Describe which type of gross motor 
outcome measures were used in eli­
gible studies.
MethODOlOGy
The eligibility criteria of studies were 
as follows:
Types of Studies:
	Randomised controlled trials (RCTs), 
non­randomised controlled trials and 
prospective case series were con­
sidered for inclusion in this review. 
	Only articles published in the English 
language were considered for eligi­
bility. 
checking one another’s appointed data­
base. The supervisor was contacted 
if no consensus was found amongst 
researchers. Pearling was also admini­
stered by both researchers.
Two researchers (KL and NN) inde­
pen dently did the data extraction from 
an article. Should the researchers fail to 
obtain the necessary information from 
an article, the authors were contacted 
to complete the data extraction. After 
the data extraction the two researchers 
compared their data. If consensus about 
the data extraction was not reached, 
the two researchers presented their 
differences to a third researcher. The 
third researcher arbitrated and if consen­
sus could still not be reached among the 
three researchers, the supervisor was 
contacted. 
A standard JBI Data Extraction form 
(Sussman & Aiona, 2004); (Bertoti, 
1988) (Sterba, 2007); (Whalen & Case­
Smith, 2011) was used to extract the 
following; study citation, study method, 
participants, interventions (treatment and 
control group), outcome measures, 
results, clinical status post­intervention 
and clinical implications. 
Data aNalysis 
Studies identified as having comparable 
data were combined using Revman© 
Review Manager software to calculate 
mean differences and 95% CI when the 
mean and standard deviations for the 
specific study was available (RevMan© 
information management system 2011). 
The mean and 95% CI were graphically 
presented using forest plots. Due to 
heterogeneity meta­analysis was not 
possible. Studies which did not provide 
mean and standard deviations could not 
be included in the forest plots but were 
included by describing their results in a 
narrative format.
ResUlts
A total of 74 hits were obtained. Of 
these, 22 abstracts were reviewed and 
12 full­text articles were subsequently 
considered as being potentially eligible 
for use in this systematic review. Of 
these 12 full­text articles, 6 articles did 
not meet the inclusion criteria. Therefore, 
6 eligible full­text articles were included 
in this systematic review (Figure 1).
	All articles published from inception 
of the databases until March 2012 
were considered.
Types of Participants:
	Male and female children aged 
between 2­12 years old. Children 
under the age of 2 years are not 
accepted for hippotherapy.
 (http://www.3gaits.org)
 13­ to 17 year olds are regarded as 
adolescence.
	Diagnosed with CP.
Types of Interventions:
	Hippotherapy or THR combined with 
usual therapies.
Types of comparisons:
	Usual therapies include any therapy 
that the child routinely participates 
in, but not only confined to 
physiotherapy, occupational therapy, 
special education or speech therapy.
Types of outcome measures:
	 Gross Motor Function Measure 
(GMFM) 66 and GMFM 88.
seaRch stRateGy
Five computerised bibliographical data­
bases accessed through the Stellen­
bosch University library services were 
searched including; CINAHL, Cochrane 
Library, Pubmed, PEDro and Science 
Direct. Database specific search strate­
gies were developed for each database. 
The following key search terms were 
used: cerebral palsy, equine­assisted 
therapy, gross motor function, hippo­
therapy and therapeutic horseback 
riding.
MethODOlOGical aPPRaisal
The PEDro scale was used to critically 
appraise the internal validity of the 
stu dies (Pearson et al 2009). Two 
researchers independently appraised 
full text of articles, and a third reviewer 
was consulted to reach consensus about 
disagreements.
 
Data eXtRactiON MethOD
Databases were searched independently 
by one researcher. Databases were then 
searched a second time by a different 
researcher, thereby automatically cross 
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None of the studies considered and 
reported on the long term effect of 
hippotherapy on children with CP. 
MethODOlOGical aPPRaisal 
The methodological quality of the final 
six articles was assessed using the 
eleven­item PEDro scale and the arti cles 
scored between 4/11 and 7/11, with an 
average score of 6.33/11 (57.57%). The 
PEDro scale, based on the Delphi list, 
consists of eleven criteria, measuring a 
study’s internal validity (criteria 2­9); 
external validity (criteria 1), as well as 
the statistical accuracy for interpretation 
purposes (criteria 10­11) (Pearson, Field 
and Jordan, 2009). Table 1 provides an 
overview of the PEDro scores. During 
the methodological appraisal of the final 
articles, it was noticed that criteria 5 
(blinding of all subjects) and 6 (blinding 
of the therapists) was impossible for this 
intervention. 
table 1: Pedro scores
PeDro criteria
casady 
& Nichols-
larsen 2004
cherng
et al.
2004
Davis
et al.
2009
Kwon
et al.
2011
MacKinnon 
et al.
1995
McGibbon 
et al.
1998
1. Eligibility criteria were specified
2. Subjects were randomly allocated to 
groups (in a crossover study, subjects 
were randomly allocated an order in 
which treatments were received)
× × ×
3. Allocation was concealed × × × × ×
4. The groups were similar at baseline 
regarding the most important 
prognostic indicators
5. There was blinding of all subjects × × × × × ×
6. There was blinding of all therapists 
who administered the therapy
× × × × × ×
7. There was blinding of all assessors 
who measured at least one key 
outcome
× × ×
8. Measures of at least one key 
outcome were obtained from more 
than 85% of the subjects initially 
allocated to groups
× ×
9. All subjects for whom outcome 
measures were available received 
the treatment or control condition as 
allocated or, where this was 
not the case, data for at least one 
key outcome was analysed by 
“intention to treat”
10. The results of between-group 
statistical comparisons are reported 
for at least one key outcome
× ×
11. The study provides both point 
measures and measures of variability 
for at least one key outcome
×
Total score 5/10 6/10 6/10 6/10 6/10 3/10
Key:
YES × NO
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table 2: study sample description
Casady & 
Nichols-Larsen 
2004
Cherng  
et al.
2004
Davis  
et al.
2009
Kwon  
et al.
2011
MacKinnon
et al.
1995
McGibbon  
et al.
1998
type of study
Quasi-
experimental 
self-control 
study
Randomised 
cross over 
control trial
Randomised 
cross over 
control trial
Non-
randomized 
prospective 
controlled 
trial
Randomised 
control trail
Repeated 
measures self-
control study
sample size
intervention 
Group
10 35 9 10 5 16
control Group 10 37 5 9 5 16
Gender
intervention 
Group
Male=6
Female=4
Male=17
Female=18
Male=7 
Female=2
Male=3
Female=7
Male=3
Female=2
Male=11
Female=5
control Group
Male =6
Female=4
Male=20
Female=17
Male=1
Female=4
Male=6
Female=3
Male=3
Female=2
Male=10
Female=6
age 
(in years)
intervention 
Group
Mean (SD):
4.1+1.7
Mean (SD):
7.4 ± 2.5
Mean (SD):
7.69 ± 2.68
Mean (SD):
7 + 2.2
Mean:
9.6
Mean (SD):
6.4 ± 1.7
control Group
Mean (SD):
4.1+1.7
Mean (SD):
7.9 ± 2.4
Mean (SD):
7.75 ± 1.60
Mean (SD):
5.85 + 1.7
Mean:
9.6
Mean (SD):
6.1 ± 1.7
country where study was 
performed
United states 
of America
Taiwan Australia Korea
United 
Kingdom
United States 
of America
SD: Standard deviation
stUDy saMPle DescRiPtiON 
A summary of the sample descriptions 
for each study is shown in Table 2.
 
DescRiPtiON OF iNteRveNtiONs
Studies either used hippotherapy or 
THR as their intervention; both were 
aimed at improving GMF by adapting 
the position or movements of the child 
while on the horse. Participants were 
encouraged to touch various parts of 
the horse or perform different tasks 
while maintaining balance and posture, 
depending on the goal of the treatment 
session. All of the studies allowed par­
ticipants in the intervention group to 
continue with their regular treatment 
which varied between the studies (Table 
3). The control groups were instructed to 
continue with their normal therapeutic 
routine as described in Table 3, except 
Kwon et al (2011) who received con­
ventional physiotherapy consisting of 
neurodevelopmental therapy. 
DescRiPtiON OF OUtcOMe Mea-
sURes
All studies used a version of the GMFM 
in order to assess gross motor function 
(Table 4). The original GMFM­88, or 
parts thereof, was used by all studies 
except Davis et al (2009), who used the 
more recent and compact GMFM­66. 
Kwon et al (2011), made use of both the 
GMFM­66 and GMFM­88. 
eFFect OF hiPPOtheRaPy cOM-
PaReD tO UsUal theRaPies
The effects of the interventions inves­
tigated are described in the following 
figures and narration, addressing each 
outcome separately.
 
GMFM – 88: Dimension a (lying 
and rolling), Dimension b (sitting) 
and Dimension c (crawling and 
kneeling)
Casady and Nichols­Larsen (2004), and 
Cherng et al (2004), reported that there 
was no statistical significant difference 
in Dimensions A and C. Three of the 
articles also reported an insignificant 
statistical difference for Dimension B 
(Casady and Nichols­Larsen, 2004, 
Cherng et al 2004 and MacKinnon et al 
1995).  Unfortunately the data was not 
available to calculate forest plots. 
GMFM – 88: Dimension D (standing) 
The mean difference reported in three 
studies favoured the hippotherapy 
group and ranged from 3.2 to 4.1 for 
the GMFM 88: Dimension D (Figure 
2).  The 95% confidence intervals were 
insignificant. 
GMFM – 88: Dimension e (walking, 
running and jumping)
The mean difference of the four 
studies reporting on Dimension E 
illustrated positive mean differences 
for hippotherapy ranging from 1.3 to 
7.7 (Figure 2).  The 95% confidence 
intervals were insignificant. 
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table 3: Description of interventions
casady & 
Nichols- 
larsen 
2004
cherng  
et. al.
2004
Davis  
et. al.
2009
Kwon  
et. al.
2011
MacKinnon 
et al. 
1995
McGibbon  
et. al.
1998
U
su
al
 t
h
er
ap
ie
s
c
o
n
tr
o
l c
o
n
d
it
io
n
	Continue 
therapies at 
school and 
clinics.
	Passive ROM 
exercises, 
positioning, 
balance 
training, 
functional 
training and 
Neuro- 
developmental 
training
	Continued 
with normal 
or daily 
routine 
including 
physiotherapy. 
(techniques 
not specified)
	Neuro- 
developmental 
therapy
	Not specified
	No attempts 
were made to 
stop routine 
therapies or 
activities in 
which the 
children were 
engaged
	Continued 
with 
normal daily 
routine.
D
u
ra
ti
o
n
	10 weeks 	16 weeks 
control
	10 weeks 	8 weeks
	Twice a week 
for 30 minutes
	26 weeks 	8 weeks
h
ip
p
o
th
er
ap
y/
 t
h
er
ap
eu
ti
c 
h
o
rs
eb
ac
k 
ri
d
in
g
in
te
rv
en
ti
o
n
	Hippo- 
therapy
	Subjects 
were 
encouraged 
to maintain 
postural 
alignment 
with 
symmetry of 
head, trunk 
and lower 
extremities.
	Sit indepen-
dently on 
horse with 
little or no 
assistance.
	Continued 
with other 
therapies 
such as 
physio-
therapy, OT 
or speech 
therapy if 
applicable`
	Therapeutic 
horseback 
riding to 
maintain good 
posture.
	Movement of 
arms including 
elevation and 
abduction of 
shoulder. 
	Trunk flexion, 
rotational 
movement 
while on the 
horse.
	Touching 
various 
parts of the 
horse’s body.
	Regular 
treatment 
continued (eg 
physiotherapy, 
occupational 
therapy 
and special 
education)
	THR with 
activities 
designed to 
emphasize 
movement in 
a forward and 
upward 
reaching 
direction.
	Continued 
with 
normal or 
daily routine 
including 
physiotherapy. 
	Hippotherapy 
for relaxation 
at start of 
each session 
feeling the 
gentle, 
rhythmical 
movement of 
the horse.
	Sustaining 
optimal 
postural 
alignment 
	Active 
exercises for 
stretching, 
strengthening, 
and dynamic 
weight shift.
	Conventional 
physiotherapy
	THR
	No attempt 
was made to 
stop routine 
therapies
	Hippo-
therapy for 
relaxation 
at start of 
each ses-
sion feeling 
the gentle, 
rhythmical 
movement 
of the horse.
	Forward 
sitting 
	Backward 
sitting (for 
thoracic 
extension 
and a more 
anterior 
pelvic tilt).
	Active 
exercises for 
stretching, 
strengthen-
ing, and 
dynamic 
weight shift.
	One child 
was receiv-
ing physical 
therapy. No 
other treat-
ments were 
initiated or 
discontinued
D
u
ra
ti
o
n
	10 weeks, 
once a 
week for 
45 minutes.
	16 weeks of 
THR twice a 
week, 
40 minute 
sessions. 
	10 week pro-
gram, once a 
week for 30-40 
minutes.
	8 weeks, twice 
a week for 30 
minutes.
	26 weeks of 
THR, once a 
week for an 
hour
	8 weeks, 
twice 
weekly for 
30 minutes.
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table 4:  Description of outcome measures used to measure gross motor function, as well as follow-up measurement intervals
Outcome Measure (OM) assessment intervals
casady & 
Nichols-larsen 
2004
	GMFM-88
-	 Dimension A (lie/ roll)
-	 Dimension B (sit)
-	 Dimension C (crawl/ kneel)
-	 Dimension D (stand)
-	 Dimension E (walking, running 
and jumping)
	Pre-test 1
	Pre-test 2
	Post-test 1
	Post-test 2
	10 week intervals
cherng et al.
2004
	GMFM-88
-	 Dimension A (lie/ roll)
-	 Dimension B (sit)
-	 Dimension C (crawl/ kneel)
-	 Dimension D (stand)
-	 Dimension E (walking, running and 
jumping)
	Baseline
	End of 16 weeks cross over
	End of 2nd period of 16 weeks
Davis et al.
2009
	GMFM-66 	Baseline
	End of 10 week intervention period
Kwon et al.
2011
	GMFM-88
-	 Dimension D (standing) 
-	 Dimension E (walking, running and 
jumping)
	GMFM 66
	Baseline
	End of 8 week intervention period
MacKinnon 
et al. 1995
	GMFM-88
-	 Dimension B (sit)
-	 Dimension D (stand)
-	 Dimension E (walking, running and 
jumping)
	Baseline
	End of 26 weeks
McGibbon et al. 
1998
	GMFM-88
-	 Dimension E (walking, running, 
jumping)
	Baseline
	Baseline after 8 weeks
	End of 8 weeks post equine assisted therapy
GMFM-88: total score
The mean difference of the studies for 
which it was possible to calculate the 
mean difference of the total GMFM­
88 score was 0.96 to 3.68 in favour of 
hippotherapy (Figure 2). 
GMFM-66: total score
The mean difference for the GMFM­
66 total score between Davis et al 
(2009) and Kwon et al (2011) indicated 
equivocal findings since the mean 
difference of Davis et al favoured usual 
therapies and Kwon et al (2011) found 
that hippotherapy in combination of 
usual therapy was superior to usual 
therapy alone (Figure 2). 
DiscUssiON
This review endeavoured to determine 
the clinical effect of hippotherapy com­
bined with usual therapies on gross 
motor function in comparison to usual 
therapies in the short as well as the 
long term. This study calculated mean 
difference and CI, which is the most 
commonly used measure of clinical effect 
(Ranstam 2012). Although statistical 
significance is often reported, clinicians 
are also guided by the magnitude of the 
effect of an intervention to ascertain if 
the therapy will have clinically meaning­
ful effect. The main finding of this review 
is that hippotherapy does not result in a 
clinically meaningful effect compared 
to usual therapies in improving gross 
motor function in children with CP.
The hippotherapy sessions varied 
between thirty minutes and an hour 
and were performed once or twice a 
week; this indicates that duration and 
frequency did not influence the effect 
of the intervention. However, the main 
finding of this review is that the clinically 
meaningful effect of hippotherapy in the 
short term is small. The tendency that 
hippotherapy results in positive effects on 
gross motor function, were also indi cted 
in a recent systematic review by Whalen 
and Case­Smith (2011), as well as a 
review by Sterba (2007). These reviews 
only reported statistical significance; 
the lack of clinically meaningful effect 
is a key shortcoming which is required 
by clinicians to assist them in deciding 
whether hippotherapy will yield added 
benefit. None of the studies considered 
and reported on the long term effect of 
hippotherapy on children with CP.
The current evidence base for the 
effect of hippotherapy on gross motor 
function is limited. Although only six 
studies were included in this review, 
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it should be noted that the search was 
limited to five databases and only papers 
published in the English language were 
eligible. This review was limited to chil­
dren between 2­12 years of age and all 
types of CP were included in order to 
broaden the search. An understanding 
of the effect of hippotherapy is further 
complicated by the variation in study 
designs. This review’s search stra­
tegy results indicated that only one 
randomised controlled clinical trial was 
eligible. A lack of randomisation is one 
key threat to internal validity which 
transpired after critical appraisal of the 
eligible studies.  Randomised controlled 
trials remain the mainstay of the highest 
level of primary research evidence due 
to the robust internal validity of a well 
conducted trial. Researchers in this 
field should conduct more randomised 
controlled trials as they are essential in 
guiding evidence based decision making 
for clinicians.
Several limitations in the included 
articles were identified. Five of the six 
studies used in this review included very 
small samples and no justification for the 
number of subjects were included.  This 
trend could be due to the high cost of 
therapy or strict inclusion criteria. The 
small sample sizes increases the risk of 
bias and were most likely of insufficient 
power to detect significant changes in 
gross motor function. Generalisation 
of the findings of individual studies 
may be limited as these relatively small 
samples are not representative of the CP 
population, therefore clinicians should 
Eligible articles for this systematic review
n = 6
Figure 1: Results of search strategy
Databases or Other Sources Initial Hits Accepted titles or 
abstracts
Duplicates between
the databases 
Cochrane 10 4
10
Ebsco Host 41 11
PEDro 10 1
Pubmed 11 3
Science Direct 31 3
TOTAL 74 22
Excluded Titles (Articles were excluded due 
to irrelevant titles)
n = 52
Accepted titles and Abstracts
n = 22
Excluded Duplicates
n = 10
Excluded full-text articles with reasons
n = 6
After re-assessing the remaining 12 accepted titles and abstracts, 12 full-text articles were retrieved and 
eligibility assessed using inclusion and exclusion criteria
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make use of meta­analyses to appraise 
the evidence. 
This review highlights the variability 
in the current evidence base for the effect 
of hippotherapy. Variation in inclusion 
criteria of subjects is one aspect which 
should be standardised in future studies. 
For instance, the inclusion criteria de­
scribed by Kwon et al (2011), required 
participants to be Level I or II on the 
gross motor function classification scale 
whilst participants in the study done by 
Cherng et al (2004), varied in function 
from crawling on belly to walking 
independently. These baseline levels 
determine the potential for improvement. 
Since subjects could already walk 
in some of the eligible studies, it is 
expected that there will be no difference 
in Dimension D of the GMFM­88 which 
measures standing ability. This aspect of 
statistical regression has been explained 
by Cherng et al (2004), who concluded 
that Dimension A and B of the GMFM­
88 was statistically insignificant due to 
the ceiling effect. Future studies should 
therefore attempt to standardise the 
eligible criteria, which will facilitate 
comparison across groups.
The studies included in this review 
are of moderate methodological quality 
as well as the moderate to high level of 
evidence on the hierarchy of evidence. 
The hierarchy of evidence is a useful tool 
that can be used to appraise the validity 
and reliability of a particular study.
 Studies reported the duration and 
frequency of the intervention as well as 
what the intervention entailed, which 
Figure 2: Forest plots
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can give therapists a guideline for 
clinical practice or it can be used for 
comparisons to either existing or future 
studies. Cherng et al (2004), Casady and 
Nichols­Larsen (2004) and Davis et al 
(2009) conducted a within participant 
repeated measure which allows more 
accurate comparison between baseline 
and post­intervention comparisons. 
Further research should be done using 
self­controls, as children with the same 
diagnosis of CP have different clinical 
presentations. 
Heterogeneity in the control condition 
of the eligible studies was notable as 
none of the studies could delineate the 
effect of hippotherapy from a specific 
type of therapy. This could be because 
it would be unethical to request that 
subject cease usual therapy.  Due to 
these variations, statistical pooling was 
impossible and the clinical effect of 
each individual study was appraised by 
calculating the mean difference and CI. 
A meta­analysis is one approach which 
can be applied to combine the findings 
of two or more primary studies and 
therefore increase the statistical power 
of primary studies. Unfortunately it was 
not possible to conduct a meta­analysis 
due to heterogeneity in study variables 
and characteristics. 
It is also plausible that other 
associated benefits such as emotional, 
cognitive, social, communication and 
increased self­esteem may influence 
the decision to include hippotherapy 
in the management of children with 
CP (Meregillano 2004).  However, the 
evidence which was systematically 
appraised in this study indicates that 
hippotherapy in conjunction with usual 
therapies does not result in a clinically 
meaningful effect compared to usual 
therapies alone. 
cliNical iMPlicatiONs aND DiRec- 
tiONs FOR FUtURe ReseaRch
Hippotherapy in combination with usual 
therapies is not superior to usual therapy 
alone, and it does not have a clinically 
meaningful effect:
•	 The clinical effect of hippotherapy is 
negligible as a minimum of 1% and a 
maximum 7% increase is expected on 
the GMFM scores. 
•	 The estimated clinical effect in the 
population is insignificant. Therefore 
clinicians need to consider factors 
such as financial cost and potential 
harm (e.g. falling off horse) when de­
ciding whether it is clinically worth­
while to include hippotherapy in the 
rehabilitation program of children 
with CP. 
Future, pragmatic, well conducted 
trials are required to provide conclusive 
evidence pertaining to the clinical effect 
of hippotherapy in children with CP.
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